Consonance Capital Management as of Sept. 30, 2014
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 26 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 13.4 | $98M | 762k | 128.65 | |
| Enanta Pharmaceuticals (ENTA) | 8.7 | $63M | 1.6M | 39.57 | |
| Taro Pharmaceutical Industries (TARO) | 6.6 | $48M | 311k | 153.86 | |
| Cardiovascular Systems | 6.3 | $46M | 1.9M | 23.63 | |
| Auxilium Pharmaceuticals | 6.1 | $45M | 1.5M | 29.85 | |
| Orthofix International Nv Com Stk | 6.1 | $45M | 1.4M | 30.96 | |
| Insys Therapeutics | 6.0 | $43M | 1.1M | 38.78 | |
| Akorn | 5.8 | $43M | 1.2M | 36.27 | |
| Abbvie (ABBV) | 4.6 | $33M | 579k | 57.76 | |
| Hyperion Therapeutics | 4.4 | $32M | 1.3M | 25.22 | |
| Pernix Therapeutics Holdings | 3.6 | $26M | 3.4M | 7.68 | |
| Anacor Pharmaceuticals In | 3.5 | $25M | 1.0M | 24.47 | |
| BioScrip | 3.0 | $22M | 3.2M | 6.91 | |
| HMS Holdings | 2.9 | $21M | 1.1M | 18.85 | |
| Osiris Therapeutics | 2.7 | $20M | 1.6M | 12.59 | |
| Biosante Pharmaceuticals (ANIP) | 2.1 | $16M | 550k | 28.28 | |
| Relypsa | 1.9 | $14M | 661k | 21.09 | |
| Retrophin | 1.9 | $14M | 1.5M | 9.02 | |
| Merrimack Pharmaceuticals In | 1.9 | $14M | 1.5M | 8.78 | |
| Derma Sciences | 1.7 | $13M | 1.5M | 8.33 | |
| Protalix BioTherapeutics | 1.7 | $12M | 5.0M | 2.42 | |
| Healthways | 1.5 | $11M | 698k | 16.02 | |
| Adma Biologics (ADMA) | 1.1 | $8.0M | 777k | 10.30 | |
| IGI Laboratories | 0.9 | $6.7M | 719k | 9.32 | |
| Aastrom Biosciences | 0.9 | $6.7M | 2.4M | 2.85 | |
| HealthStream (HSTM) | 0.6 | $4.2M | 174k | 24.01 |
